Medlab Clinical Limited
AASX:MDCShare Statistics
As of June 30, 2024, Medlab Clinical Limited has 2.28M shares outstanding.
| Shares Outstanding | 2.28M |
Financial Position
As of June 30, 2024, Medlab Clinical Limited maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Interest Coverage | -4,286.09 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2024. Return on assets (ROA) is negative at -130.89, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -130.89 |
Margins
Over the twelve months ended June 30, 2024, Medlab Clinical Limited posted a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -18,990.81 and net profit margin of -17,913.57 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -18,990.81 |
| Pretax Margin | -17,916.02 |
| Profit Margin | -17,913.57 |
| EBITDA Margin | -18,990.81 |
Stock Splits
Medlab Clinical Limited's most recent stock split took place on August 2, 2022 with a 150:1 split ratio.
| Last Split Date | 8/2/2022 |
| Split Ratio | 150:1 |
Scores
As of June 30, 2024, Medlab Clinical Limited has an Altman Z-Score of -926.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -926.48 |